A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in …

SP Ribeiro, VGDM Mattaraia, RR Almeida… - Vaccine, 2022 - Elsevier
Over the last few decades, several emerging or reemerging viral diseases with no readily
available vaccines have ravaged the world. A platform to fastly generate vaccines inducing …

[引用][C] A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in …

SP Ribeiro, VGM Mattaraia, RR Almeida… - Vaccine, 2022 - repositorio.usp.br
ReP USP - Detalhe do registro: A promiscuous T cell epitope-based HIV vaccine providing
redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses …

A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in …

SP Ribeiro, VGM Mattaraia, RR Almeida - Vaccine, 2022 - pesquisa.bvsalud.org
Over the last few decades, several emerging or reemerging viral diseases with no readily
available vaccines have ravaged the world. A platform to fastly generate vaccines inducing …

A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in …

SP Ribeiro, VGM Mattaraia, RR Almeida - Vaccine, 2022 - repositorio.butantan.gov.br
Over the last few decades, several emerging or reemerging viral diseases with no readily
available vaccines have ravaged the world. A platform to fastly generate vaccines inducing …

A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in …

SP Ribeiro, VGDM Mattaraia, RR Almeida… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Over the last few decades, several emerging or reemerging viral diseases with no readily
available vaccines have ravaged the world. A platform to fastly generate vaccines inducing …

A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class ii elicits broad, polyfunctional T cell responses in …

SP Ribeiro, VG De Moura Mattaraia, RR Almeida… - 2022 - cabidigitallibrary.org
Over the last few decades, several emerging or reemerging viral diseases with no readily
available vaccines have ravaged the world. A platform to fastly generate vaccines inducing …

A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in …

SP RIBEIRO, VGDM MATTARAIA, RR ALMEIDA… - Vaccine, 2022 - observatorio.fm.usp.br
Over the last few decades, several emerging or reemerging viral diseases with no readily
available vaccines have ravaged the world. A platform to fastly generate vaccines inducing …

A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in …

SP Ribeiro, VG De Moura Mattaraia, RR Almeida… - Vaccine, 2021 - europepmc.org
Over the last few decades, several emerging or reemerging viral diseases with no readily
available vaccines have ravaged the world. A platform to fastly generate vaccines inducing …

[引用][C] A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in …

SP Ribeiro, VGDM Mattaraia, RR Almeida… - 2022